LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028

Market by Gender, End-user, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s report expects the Latin America infertility testing and treatment market to progress at a CAGR of 9.71% during the evaluated phase 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries scrutinized in this market include:

•        Brazil

•        Mexico

•        Rest of Latin America

The Brazilian market is anticipated to witness significant growth over the forecast period, owing to the rise in infertility rates among the population. Furthermore, the rising awareness relating to infertility has enhanced the demand for infertility treatments across the country. Other than this, the high alcohol intake, smoking, obesity, stress, and other lifestyle diseases have increased the need for infertility testing to a large extent. Hence, such factors are likely to create new opportunities for the infertility testing and treatment market to leverage to read its anticipated growth in Brazil.

Furthermore, in Mexico, the studied market’s growth is supported by factors like the growing number of infertility cases, rising obesity levels, pollution, and the increasing number of smokers. Additionally, Polycystic Ovary syndrome (PCOS) is considered to majorly impact the fertility level among women, increasing the need for infertility treatments.

Other than this, the availability of technologically advanced infertility treatment devices adds to the market’s growth. Above all, the growing number of clinically advanced fertility centers adds to the market’s growth. For instance, LIV Fertility Center offers semen analysis, sperm processing, and comprehensive male infertility services. Here, the sperm sorting technology is based on flow cytometry integrated with special software, maximizing the sorting efficiency. Hence, all these factors are anticipated to support Mexico’s infertility testing and treatment market’s development.

Endo International Plc is a specialty branded and pharmaceutical company operating under the segment such as pharmaceuticals, sterile injectables, generic pharmaceuticals, and others. Its product portfolio includes TESTOPEL, a testosterone pellet that helps restore testosterone levels within three to four months. Endo serves clients across various regions, including Latin America. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. KEY INSIGHTS

2.1.1. GROWING DEMAND FOR LOW-COST PROCEDURES

2.1.2. INCREASING ACCEPTANCE OF DONOR EGGS

2.1.3. USE OF AI INCREASES THE SUCCESS OF IVF TREATMENT

2.2. IMPACT OF COVID-19 ON INFERTILITY TESTING AND TREATMENT MARKET

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE

2.3.3. BARGAINING POWER OF SUPPLIERS

2.3.4. BARGAINING POWER OF BUYERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. KEY BUYING IMPACT ANALYSIS

2.4.1. TREATMENT OPTIONS

2.4.2. QUALITY OF MEDICAL PROCEDURES

2.4.3. PRICE OF TREATMENTS

2.4.4. SHIFT TOWARDS MEDICAL TOURISM

2.4.5. REIMBURSEMENT

2.5. MARKET ATTRACTIVENESS MATRIX

2.6. INDUSTRY COMPONENTS

2.6.1. RAW MATERIAL PROCUREMENT

2.6.2. MANUFACTURING

2.6.3. SUPPLY LOGISTICS

2.6.4. DISTRIBUTION CHANNELS

2.6.5. END-USERS

2.7. VENDOR SCORECARD

2.8. KEY MARKET STRATEGIES

2.8.1. CONTRACTS & PARTNERSHIPS

2.8.2. ACQUISITIONS & MERGERS

2.8.3. NEW PRODUCT LAUNCHES

2.9. MARKET DRIVERS

2.9.1. GROWTH IN STRESS AND LIFESTYLE DISORDERS

2.9.2. RISING TREND IN DEPLAYED MARRIAGES AND PREGNANCIES

2.9.3. IMPROVEMENTS IN TREATMENTS

2.9.4. GOVERNMENT SUPPORT

2.10. MARKET CHALLENGES

2.10.1. HIGH COST

2.10.2. SOCIAL TABOO PERTAINING TO INFERTILITY

2.10.3. RISKS ASSOCIATED WITH TREATMENTS

2.11. MARKET OPPORTUNITIES

2.11.1. TECHNOLOGY ADVANCEMENTS IN TIME-LAPSE TECHNOLOGY

2.11.2. ADVANCES IN EMBRYO BIOPSY AND GENETIC SCREENING

3. LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET – BY GENDER

3.1. MALE

3.1.1. MALE INFERTILITY TESTING

3.1.1.1. DNA FRAGMENTATION

3.1.1.2. OXIDATIVE STRESS ANALYSIS

3.1.1.3. SPERM PENETRATION ASSAY

3.1.1.4. COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)

3.1.1.5. SPERM AGGLUTINATION

3.1.1.6. MICROSCOPIC EXAMINATION

3.1.1.7. OTHERS

3.1.2. MALE INFERTILITY TREATMENT

3.1.2.1. MEDICATION

3.1.2.2. ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY

3.2. FEMALE

3.2.1. FEMALE INFERTILITY TESTING

3.2.1.1. OVULATION TESTING

3.2.1.2. HYSTEROSALPINGOGRAPHY

3.2.1.3. LAPAROSCOPY

3.2.1.4. TRANSVAGINAL ULTRASOUND

3.2.1.5. OVARIAN RESERVE TESTING

3.2.1.6. HORMONAL LEVEL TESTING

3.2.1.7. OTHERS

3.2.2. FEMALE INFERTILITY TREATMENT

3.2.2.1. IVF WITH ICSI

3.2.2.2. IUI

3.2.2.3. IVF WITHOUT ICSI

3.2.2.4. SURROGACY

3.2.2.5. THERS

4. LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET - BY END-USER

4.1. FERTILITY AND SURGICAL CENTERS

4.2. HOSPITALS & RESEARCH LABORATORIES

4.3. CRYOBANKS

5. LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET – REGIONAL OUTLOOK

5.1. BRAZIL

5.2. MEXICO

5.3. REST OF LATIN AMERICA

6. COMPETITIVE LANDSCAPE

6.1. ADORFEM

6.2. BANGKOK IVF CENTER

6.3. COOK MEDICAL INC

6.4. COOPER SURGICAL

6.5. CREATE FERTILITY CENTRE

6.6. EMD GROUP (MERCK KGAA)

6.7. ENDO INTERNATIONAL PLC

6.8. FERRING PHARMACEUTICALS

6.9. HALOTECH DNA

6.10. GENEA LTD

6.11. FUJIFILM IRVINE SCIENTIFIC

6.12. VITROLIFE AB

6.13. LABOTECT GMBH

6.14. OLYMPUS CORPORATION

6.15. PROGYNY

7. METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.2. SOURCES OF DATA

7.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2: MARKET ATTRACTIVENESS MATRIX

TABLE 3: VENDOR SCORECARD

TABLE 4: LIST OF CONTRACTS & PARTNERSHIPS

TABLE 5: LIST OF ACQUISITIONS & MERGERS

TABLE 6: LIST OF NEW PRODUCT LAUNCHES

TABLE 7: AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS

TABLE 8: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)

TABLE 9: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

TABLE 10: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 11: PROS AND CONS OF DNA SHARING METHODS

TABLE 12: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 13: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

TABLE 14: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 15: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 16: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 17: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: KEY BUYING IMPACT ANALYSIS

FIGURE 3: INDUSTRY COMPONENTS

FIGURE 4: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2020 & 2028 (IN %)

FIGURE 5: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

FIGURE 6: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2020 & 2028 (IN %)

FIGURE 7: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

FIGURE 8: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2020 & 2028 (IN %)

FIGURE 9: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY DNA FRAGMENTATION, 2021-2028 (IN $ MILLION)

FIGURE 10: CAUSES OF SPERM DNA FRAGMENTATION

FIGURE 11: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY OXIDATIVE STRESS ANALYSIS, 2021-2028 (IN $ MILLION)

FIGURE 12: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY SPERM PENETRATION ASSAY, 2021-2028 (IN $ MILLION)

FIGURE 13: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA), 2021-2028 (IN $ MILLION)

FIGURE 14: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY SPERM AGGLUTINATION, 2021-2028 (IN $ MILLION)

FIGURE 15: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MICROSCOPIC EXAMINATION, 2021-2028 (IN $ MILLION)

FIGURE 16: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 17: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

FIGURE 18: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2020 & 2028 (IN %)

FIGURE 19: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MEDICATION, 2021-2028 (IN $ MILLION)

FIGURE 20: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 21: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

FIGURE 22: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2020 & 2028 (IN %)

FIGURE 23: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

FIGURE 24: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2020 & 2028 (IN %)

FIGURE 25: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY OVULATION TESTING, 2021-2028 (IN $ MILLION)

FIGURE 26: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY HYSTEROSALPINGOGRAPHY, 2021-2028 (IN $ MILLION)

FIGURE 27: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)

FIGURE 28: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY TRANSVAGINAL ULTRASOUND, 2021-2028 (IN $ MILLION)

FIGURE 29: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY OVARIAN RESERVE TESTING, 2021-2028 (IN $ MILLION)

FIGURE 30: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY HORMONAL LEVEL TESTING, 2021-2028 (IN $ MILLION)

FIGURE 31: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 32: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

FIGURE 33: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2020 & 2028 (IN %)

FIGURE 34: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY IVF WITH ICSI, 2021-2028 (IN $ MILLION)

FIGURE 35: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY IUI, 2021-2028 (IN $ MILLION)

FIGURE 36: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY IVF WITHOUT ICSI, 2021-2028 (IN $ MILLION)

FIGURE 37: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY SURROGACY, 2021-2028 (IN $ MILLION)

FIGURE 38: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 39: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2020 & 2028 (IN %)

FIGURE 40: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FERTILITY AND SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

FIGURE 41: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY HOSPITALS & RESEARCH LABORATORIES, 2021-2028 (IN $ MILLION)

FIGURE 42: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY CRYOBANKS, 2021-2028 (IN $ MILLION)

FIGURE 43: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 44: BRAZIL INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 45: MEXICO INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 46: REST OF LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;